PREP

What can we help you find?
[[thumbnail_alt_text]]
Top news of the day from across the health care landscape.
[[thumbnail_alt_text]]
Administered through a drug-eluting implant, islatravir demonstrated protection against HIV for up to 12 months.
[[thumbnail_alt_text]]
Top news of the day from across the health care landscape.
[[thumbnail_alt_text]]
Health care professionals, including pharmacists and nurse practitioners, play a critical role in attaining goals for reducing HIV transmission. 
[[thumbnail_alt_text]]
Due to physician shortages, pharmacists represent a new avenue to increase accessibility to antivirals.
[[thumbnail_alt_text]]
Introduced by U.S. Senator Kamala D. Harris (D-CA), the bill requires all insurance plans to cover HIV prevention medications and services without out-of-pocket costs. The bill also facilitates access to PrEP for uninsured individuals.
[[thumbnail_alt_text]]
Top news of the day from across the health care landscape.
[[thumbnail_alt_text]]
Expansion to adolescents, flexible dosing strategies, innovative delivery models, and long-acting antiretrovirals all help the strategy. 
[[thumbnail_alt_text]]
An agreement between the US Department of Health and Human Services and Gilead will provide HIV prevention drugs to uninsured individuals who are at risk.
[[thumbnail_alt_text]]
Top news of the day from across the health care landscape.
[[thumbnail_alt_text]]
Overall, more than half of commercially insured individuals who initiated pre-exposure prophylaxis persisted with it for the 12-month duration of the cohort study.
[[thumbnail_alt_text]]
Vaginal inserts containing tenofovir alafenamide fumarate in combination with elvitegravir were shown to be highly effective in preventing simian/HIV infection in a macaque model.